Oil and Gas E&P to Spin Out Assets
  (6/15/22)
"The market is pricing in very little for the new company, and given our expectations for continued strong oil prices, we believe this is a buying opportunity," noted a Research Capital Corp. report regarding Pan Orient Energy Corp. More >

Mining Co. Hits Some of Its Best Drill Results to Date
  (6/14/22)
The explorer's latest drill results are some of the best reported to date at its silver-gold project, noted a Research Capital Corp. report. More >

Healthcare Tech Firm Improves Earnings and Cash Flow in Q3/22
  (6/14/22)
These changes earned Reliq Health Technologies Inc. an upgrade in overall rating by independent investment research and advisory firm, Jefferson Research. More >

Junior Hits Highest Grades Yet in Colombia
Source: Streetwise Reports  (6/13/22)
Santa Ana was once the biggest colonial silver mine in Colombia. Today one junior explorer is looking to return Santa Ana to its previous glory, and some recent bonanza-grade drill results show the old mining district has plenty left to give. More >

Gold Co. Shows Promising Drill Results Despite Economic Pressure, Says Expert
Source: The Critical Investor  (6/13/22)
Gold Terra Resource Corp. has some ambitious plans as they continue to drill their 30,000m program, and the most recently announced results 'continue to impress.' More >

NevGold Adds Nutmeg to Mix
Source: Streetwise Reports  (6/13/22)
One junior explorer just added a project in Idaho to a healthy stable of assets. Management believes the deal creates a lot of upside for shareholders, as the focus now turns toward extracting that value. More >

Exploration Deals and Results at Top Resource Companies
Source: Adrian Day  (6/13/22)
Today expert Adrian Day runs over the latest updates in deals and exploration from Midland Exploration, Orogen Royalties, and Fortuna Silver to tell you which ones he believes are a Buy. More >

Investors Gain a Breath of Fresh Air From Ph. 3 CS Trial Results
Source: Streetwise Reports  (6/13/22)
Optinose Inc. shares traded 40% higher after the company reported positive top-line data from its Phase 3 ReOpen2 Trial of XHANCE for use in treating chronic sinusitis without nasal polyps. More >

Expert Says, 'Inflationary Angst Is Here'
Source: Michael J. Ballanger  (6/13/22)
Expert Michael Ballanger shares his thoughts on the Fed's actions to combat interest rates, the "angst" gold investors may be feeling at the present moment, and what he believes we should do next. More >

Junior Buys Possible IOCG Project in Chilean Mining District
Source: Streetwise Reports  (6/10/22)
Could this aspiring junior have the next company-maker IOCG deposit on its hands? One junior explorer operating in Chile recently acquired 18,000 hectares between one giant copper mine and another massive development-stage project. Management thinks this could be another success story for a company with a history of turning little into lots.
More >

Junior Speeds Up Drill Program in Spain
Source: Streetwise Reports  (6/10/22)
Mining along the Iberian Peninsula has occurred for thousands of years. Today, one company is again exploring the Iberian Pyrite Belt as part of an effort to quickly build a resource and join the ranks of Spain’s metals producers. More >

Biopharma Co.'s New Diabetes Drug Candidate Shows Promise
  (6/10/22)
Biomea Fusion Inc.'s new menin inhibitor is soon to begin clinical human trials after it restored glycemic control and outperformed the standard of care, in animal models. More >

New Drug for Peanut Allergy in Toddlers Shown Safe and Effective
  (6/10/22)
The response rate to DBV Technologies SA's drug patch in the recent Phase 3 clinical trial was statistically significant, which bodes well for the company as there is currently no approved therapy for children with this condition. More >

Biotech Co.'s Shares Soar on Ph. 2 Hematology Trial Results
Source: Streetwise Reports  (6/10/22)
Cogent Biosciences Inc. shares traded 70% higher after the firm reported positive clinical data from Part 1 of its ongoing Phase 2 APEX trial evaluating bezuclastinib in patients with advanced systemic mastocytosis (AdvSM), a severe hematologic disorder. More >

Explorer Renews Rare Earths Campaign in BC
Source: Streetwise Reports  (6/9/22)
This company is getting drills turning and renewing its search for rare earth elements in Canada, hoping to reduce the West’s dependence on resources from China. More >

More Positive Drill Results From Mining Co.
  (6/9/22)
New findings bode well for Troilus Gold Corp.'s imminent mineral resource estimate and subsequent prefeasibility study. More >

Mining Firm to Drill Large Deposit With Great Upside in 2022
  (6/9/22)
Emerita Resources Corp. has an ambitious goal of completing 70,000 meters using six rigs at their Spanish project, and recent electromagnetic surveys indicate even greater potential than originally thought. More >

Mining Co. Discovers a Major High-Grade Gold Deep Feeder Structure
  (6/9/22)
One drillhole returned the longest, high-grade intercept to date at the Fiji project, 20.86 grams per ton gold over 75.9 meters, a "potential game changer" in Lion One's development. More >

World's Leading Diamond Retailer's Sales Rise 8.9% in Q1
Source: Streetwise Reports  (6/9/22)
Signet Jewelers Ltd. shares traded 9% higher after the company reported Q1/23 financial results and reaffirmed its FY/23 estimates for total revenue and non-GAAP operating income. More >

Good Chance FDA Will Greenlight Solution for Dry Eye Disease
  (6/9/22)
Approval would be positive news for Aldeyra Therapeutics Inc. given the market for the indication is large and underserved, noted a BTIG report. More >

Gold Assets Could Help Secure Nation's Shores
Source: Streetwise Reports  (6/8/22)
This North American natural resource explorer is advancing the potential of its key gold projects at the 60th parallel of Canada’s Northwest Territories. More >

Small Biomedical Device Co. Is Ready to Take a Big Step Into Success
Source: Tim Weintraut  (6/8/22)
After weathering some major setbacks, PetVivo Holdings Inc. is stepping it up. With their new product for osteoarthritis and the team's perseverance, they may soon show themselves as a diamond in the rough. More >

Biopharma Co. Meets Primary Endpoints in ARDS Trial
Source: Streetwise Reports  (6/8/22)
MediciNova Inc. shares traded 9% higher after the company released top-line data from its Phase 2 study of MN-166 (ibudilast) in hospitalized COVID-19 patients deemed to be at elevated risk for acute respiratory distress syndrome. In the study, MN-166 demonstrated significant decreases in respiratory failure. More >

Analyst Predicts Mining Co. Could Rise 295% After ESIA Approval
  (6/7/22)
The valuation of this company is expected to rise as it advances through project permitting processes, environmental approvals, financing, local agreements and more, noted a Velocity Trade Capital report. More >

Mining Co. Wins Small Victory in Ongoing Legal Dispute
  (6/7/22)
The Spanish administrative and criminal cases concerning the 2015 granting of a mining project tender now will be heard consecutively rather than simultaneously, noted a Research Capital Corp. report. More >